Study guide

13.1 Acute Respiratory Distress Syndrome (ARDS) in Trauma

BCEN TCRN Trauma Certified Registered Nurse Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Head & Neck Trauma I - Traumatic Brain Injury & ICP

1.1 Primary vs. Secondary Brain Injury & Pathophysiology 1.2 Intracranial Pressure (ICP) Monitoring & Monroe-Kellie Doctrine 1.3 Cerebral Perfusion Pressure (CPP) & Medical Management of Elevated ICP 1.4 Herniation Syndromes & Acute Surgical TBI Interventions

2 Chapter 2: Head & Neck Trauma II - Maxillofacial, Ocular & Spinal Cord Trauma

2.1 Maxillofacial Trauma & Airway Management (Le Fort & Mandibular Fractures) 2.2 Ocular Trauma Assessment & Emergency Interventions 2.3 Penetrating & Blunt Neck Trauma (Zone I-III Management) 2.4 Cervical & Upper Spinal Cord Injury (Neurogenic Shock vs. Spinal Shock & ASIA Scale)

3 Chapter 3: Thoracic Trauma I - Immediate Life-Threatening Airway & Chest Injuries

3.1 Tension Pneumothorax, Simple Pneumothorax & Needle Decompression 3.2 Open Pneumothorax & Massive Hemothorax Management 3.3 Cardiac Tamponade & Resuscitative Thoracotomy Indications 3.4 Tracheobronchial Disruption & Flail Chest with Pulmonary Contusion

4 Chapter 4: Thoracic Trauma II - Vascular, Parenchymal & Diaphragmatic Injuries

4.1 Blunt Cardiac Injury (BCI) & Myocardial Contusion Monitoring 4.2 Traumatic Aortic Disruption (TAD) & Great Vessel Injury 4.3 Esophageal Perforation & Penetrating Thoracic Trauma 4.4 Diaphragmatic Rupture & Thoracic Surgical Indications

5 Chapter 5: Abdominal Trauma - Solid Organ, Hollow Viscus & Abdominal Compartment Syndrome

5.1 Hepatic & Splenic Trauma Grading & Non-Operative Management 5.2 Hollow Viscus & Mesenteric Injury (Bowel Perforation & Peritonitis) 5.3 FAST Exam, Diagnostic Peritoneal Lavage (DPL) & Abdominal CT Indications 5.4 Retroperitoneal Hemorrhage & Abdominal Compartment Syndrome (ACS)

6 Chapter 6: Pelvic & Genitourinary Trauma

6.1 Pelvic Fracture Classification & Biomechanical Instability 6.2 Acute Pelvic Hemorrhage Control (Pelvic Binders, Angiography & REBOA) 6.3 Bladder & Urethral Trauma (High-Riding Prostate & Retrograde Urethrography) 6.4 Renal & Ureteral Trauma Management

7 Chapter 7: Musculoskeletal Extremity Trauma & Compartment Syndrome

7.1 Open Fractures & Gustilo-Anderson Classification 7.2 Traumatic Amputations & Mangled Extremity Severity Score (MESS) 7.3 Extremity Vascular Injury (Hard vs. Soft Signs & Ankle-Brachial Index) 7.4 Compartment Syndrome & Fasciotomy Indications

8 Chapter 8: Wound Care, Soft Tissue & Burn Trauma

8.1 Soft Tissue Trauma, Crush Injury & Rhabdomyolysis 8.2 Burn Depth Assessment & Total Body Surface Area (TBSA) Calculation 8.3 Parkland Formula & Fluid Resuscitation Protocols for Burns 8.4 Inhalation Injury, Escharotomy & Burn Wound Care

9 Chapter 9: Special Populations I - Pediatric & Geriatric Trauma

9.1 Pediatric Trauma Airway, Breathing & Physiologic Differences 9.2 Pediatric Fluid Resuscitation, Vital Signs & Child Abuse/NAT Recognition 9.3 Geriatric Trauma Physiology, Frailty & Medication Effects (Anticoagulants/Beta Blockers) 9.4 Geriatric Rib Fractures, Fall Mechanisms & Traumatic Brain Injury

10 Chapter 10: Special Populations II - Pregnancy, Bariatric & Vulnerable Populations

10.1 Pregnant Trauma Patient Physiologic Adaptation & Supine Hypotensive Syndrome 10.2 Fetal Assessment, Kleihauer-Betke Test & Perimortem Cesarean Delivery 10.3 Bariatric Trauma Considerations & Airway/Resuscitation Challenges 10.4 Intimate Partner Violence, Human Trafficking & Substance Use in Trauma

11 Chapter 11: Initial Trauma Assessment & Airway Management

11.1 Triage Systems & Trauma Center Levels I-IV 11.2 Primary Survey (ABCDE) & Rapid Trauma Assessment 11.3 Airway Management & Rapid Sequence Intubation (RSI) in Trauma 11.4 Secondary Survey (FGHIJ) & AMPLE History Collection

12 Chapter 12: Trauma Shock & Damage Control Resuscitation

12.1 Pathophysiology & Classification of Shock in Trauma 12.2 Massive Transfusion Protocol (MTP) & Balanced 1:1:1 Blood Product Resuscitation 12.3 Viscoelastic Hemostatic Assays (TEG/ROTEM) & Tranexamic Acid (TXA) 12.4 Damage Control Resuscitation, Permissive Hypotension & Lethal Triad Prevention

13 Chapter 13: Post-Resuscitation Critical Care & Complications

13.1 Acute Respiratory Distress Syndrome (ARDS) in Trauma 13.2 Disseminated Intravascular Coagulation (DIC) & Trauma-Induced Coagopathy (TIC) 13.3 Systemic Inflammatory Response Syndrome (SIRS), Sepsis & MODS 13.4 Invasive Hemodynamic Monitoring & Hypothermia Prevention

14 Chapter 14: Rehabilitation, Psychosocial Support & Transition of Care

14.1 Acute Stress Response, PTSD Screening & Trauma Psychosocial Support 14.2 Family-Centered Care & End-of-Life/Brain Death Determination 14.3 Organ Donation Protocols & Donor Management in Trauma 14.4 Inter-Facility Transfer Protocols (EMTALA/COBRA) & Discharge Planning

15 Chapter 15: Professional Practice, Quality & Disaster Management

15.1 Trauma Registry & Performance Improvement and Patient Safety (PIPS) 15.2 Mass Casualty Triage (START/JumpSTART) & Incident Command System (ICS) 15.3 Legal, Ethical & Forensic Evidence Preservation in Trauma Nursing 15.4 Secondary Traumatic Stress, Nurse Resilience & Team Well-being

13.1 Acute Respiratory Distress Syndrome (ARDS) in Trauma

Key Takeaways Explain This Topic AI

The Berlin definition categorizes ARDS severity based on PaO2/FiO2 ratio on PEEP ≥ 5 cmH2O: Mild (200-300 mmHg), Moderate (100-200 mmHg), and Severe (≤ 100 mmHg).

Lung-protective ventilation mandates low tidal volumes of 4-8 mL/kg based strictly on predicted body weight (derived from height and sex) to keep plateau pressure ≤ 30 cmH2O.

Permissive hypercapnia (pH ≥ 7.20-7.25) is an accepted trade-off of low tidal volume ventilation but is strictly contraindicated in traumatic brain injury with elevated intracranial pressure.

Prone positioning for at least 16 hours daily in severe ARDS (PaO2/FiO2 < 150 mmHg) improves V/Q matching, recruits dorsal alveoli, and significantly reduces mortality.

Last updated: July 2026

13.1 Acute Respiratory Distress Syndrome (ARDS) in Trauma

Clinical Summary: Acute Respiratory Distress Syndrome (ARDS) is a devastating inflammatory lung injury triggered by direct thoracic trauma or systemic inflammatory insults. Management centers on early recognition via Berlin criteria, lung-protective mechanical ventilation with low tidal volumes (4-8 mL/kg predicted body weight), plateau pressure restriction (< 30 cmH2O), recruitment via PEEP, and rescue prone positioning.

Acute Respiratory Distress Syndrome (ARDS) represents one of the most severe pulmonary complications encountered in post-resuscitation trauma critical care. Characterized by diffuse alveolar damage, alveolar-capillary membrane disruption, non-cardiogenic pulmonary edema, and profound hypoxemia, ARDS develops in up to 25% of critically injured trauma patients. Recognizing the clinical drivers, diagnostic parameters, and lung-protective ventilation strategies is essential for the Trauma Certified Registered Nurse (TCRN).

Etiology and Pathophysiology in the Trauma Patient

ARDS in trauma results from either direct (primary pulmonary) or indirect (secondary systemic) pulmonary insults. Direct trauma causes direct structural disruption of pulmonary tissue, whereas indirect insults induce a systemic inflammatory cascade that damages the alveolar-capillary unit secondarily.

Category Primary Etiologies in Trauma Pathophysiologic Mechanism

Direct Pulmonary Insults Pulmonary contusion, gastric aspiration, thoracic blast injury, toxic inhalation, near-drowning Direct physical or chemical destruction of alveolar epithelium and capillary endothelium

Indirect Systemic Insults Severe hemorrhagic shock, massive blood transfusion (TRALI), systemic sepsis, fat embolism syndrome, severe pancreatitis Systemic neutrophil activation, circulating cytokine surge (IL-1, IL-6, TNF- α \alpha α ), microvascular entrapment

The Inflammatory Cascade

The pathophysiologic progression of ARDS occurs across three distinct phases:

Exudative Phase (Days 1–7): Damaged vascular endothelium and alveolar epithelium allow protein-rich fluid to leak into the interstitial and alveolar spaces. Neutrophils infiltrate the pulmonary parenchyma, releasing reactive oxygen species, proteases, and pro-inflammatory cytokines. Surfactant inactivation causes widespread alveolar collapse (microatelectasis), resulting in severe ventilation-perfusion (V/Q) mismatching and intrapulmonary shunting. Fibrin and cellular debris form hyaline membranes along alveolar walls.

Proliferative Phase (Days 7–21): Fibroblasts proliferate within the alveolar interstitium. Type II pneumocytes attempt to regenerate alveolar epithelium, but persistent inflammation leads to progressive alveolar thickening and reduced pulmonary compliance.

Fibrotic Phase (Day 21+): Extensive remodeling leads to irreversible pulmonary fibrosis, loss of vascular bed area, and chronic pulmonary hypertension.

Diagnostic Criteria: The Berlin Definition

ARDS diagnosis is established using the international Berlin Definition criteria. The trauma nurse must verify that all four diagnostic components are met: Berlin ARDS Diagnostic Criteria:

├── Timing: Within 1 week of a known clinical insult or new/worsening respiratory symptoms

├── Chest Imaging: Bilateral opacities on chest radiograph or CT scan (not fully explained by effusions, collapse, or nodules)

├── Origin of Edema: Respiratory failure not fully explained by cardiac failure or fluid overload (objective assessment e.g., echocardiogram required if no risk factor present)

└── Oxygenation Impairment (with PEEP or CPAP ≥ 5 cmH2O):

  • ├── Mild ARDS: 200 mmHg < PaO2/FiO2 ≤ 300 mmHg
  • ├── Moderate ARDS: 100 mmHg < PaO2/FiO2 ≤ 200 mmHg
  • └── Severe ARDS: PaO2/FiO2 ≤ 100 mmHg

Note on Calculation: The P a O 2 / F i O 2 PaO_2/FiO_2 P a O 2 ​ / F i O 2 ​ (P/F) ratio is calculated by dividing arterial oxygen tension ( P a O 2 PaO_2 P a O 2 ​ in mmHg) by the fractional inspired oxygen ( F i O 2 FiO_2 F i O 2 ​ expressed as a decimal). For example, a patient on F i O 2 FiO_2 F i O 2 ​ 0.60 (60%) with a P a O 2 PaO_2 P a O 2 ​ of 90 mmHg has a P/F ratio of 90 / 0.60 = 150 mmHg 90 / 0.60 = 150 \text{ mmHg} 90/0.60 = 150 mmHg (Moderate ARDS).

Mechanical Ventilation & Lung-Protective Strategies

Standard ventilation practices with high tidal volumes exacerbate lung injury through volutrauma (overdistension), barotrauma (excessive airway pressures), and atelectrauma (repetitive alveolar opening and collapse). The cornerstone of ARDS management is Low Tidal Volume Ventilation (LTVV) based on the landmark ARDSNet protocol.

Low Tidal Volume Protocol (ARDSNet)

Predicted Body Weight (PBW): Tidal volume ( V t V_t V t ​ ) must be calculated using Predicted Body Weight (PBW) based on patient height and biological sex—never actual body weight. Actual weight reflects adipose tissue and fluid accumulation, whereas adult lung volume is determined purely by height and sex.

Male PBW (kg): 50 + 0.91 × ( height in cm − 152.4 ) 50 + 0.91 \times (\text{height in cm} - 152.4) 50 + 0.91 × ( height in cm − 152.4 )

Female PBW (kg): 45.5 + 0.91 × ( height in cm − 152.4 ) 45.5 + 0.91 \times (\text{height in cm} - 152.4) 45.5 + 0.91 × ( height in cm − 152.4 )

Initial Setting: Initiate ventilation at 6 mL/kg PBW 6 \text{ mL/kg PBW} 6 mL/kg PBW , titrating down by 1 mL/kg 1 \text{ mL/kg} 1 mL/kg decrements every 2 hours to a minimum of 4 mL/kg PBW 4 \text{ mL/kg PBW} 4 mL/kg PBW if necessary to maintain target airway pressures.

Plateau Pressure ( P p l a t P_{plat} P pl a t ​ ) Target: Measure end-inspiratory pause pressure ( P p l a t P_{plat} P pl a t ​ ). Maintain P p l a t ≤ 30 cmH 2 O P_{plat} \le 30 \text{ cmH}_2\text{O} P pl a t ​ ≤ 30 cmH 2 ​ O . Elevated plateau pressure correlates directly with alveolar overdistension and barotrauma.

Driving Pressure ( Δ P \Delta P Δ P ): Calculated as Δ P = P p l a t − P E E P \Delta P = P_{plat} - PEEP Δ P = P pl a t ​ − PEEP . Targeting a driving pressure < 14 – 15 cmH 2 O < 14\text{--}15 \text{ cmH}_2\text{O} < 14 – 15 cmH 2 ​ O optimizes dynamic compliance and reduces mortality.

Permissive Hypercapnia

Reducing tidal volumes frequently results in hypercapnic respiratory acidosis. Permissive hypercapnia is accepted to protect the lungs, allowing arterial P a C O 2 PaCO_2 P a C O 2 ​ to rise (typically 45 – 65 mmHg 45\text{--}65 \text{ mmHg} 45 – 65 mmHg ) provided systemic pH is maintained ≥ 7.20 – 7.25 \ge 7.20\text{--}7.25 ≥ 7.20 – 7.25 . Critical Exception: Permissive hypercapnia is strictly contraindicated in patients with co-existing Traumatic Brain Injury (TBI) and elevated Intracranial Pressure (ICP). Elevated P a C O 2 PaCO_2 P a C O 2 ​ causes cerebral vasodilation, increasing cerebral blood volume and precipitously raising ICP.

PEEP Titration & Alveolar Recruitment

Positive End-Expiratory Pressure (PEEP) maintains alveolar patency at end-expiration, preventing atelectrauma and expanding functional residual capacity (FRC). Higher PEEP ( 10 – 20 cmH 2 O 10\text{--}20 \text{ cmH}_2\text{O} 10 – 20 cmH 2 ​ O ) is titrated using high-PEEP/lower- F i O 2 FiO_2 F i O 2 ​ tables to achieve arterial oxygenation goals ( P a O 2 PaO_2 P a O 2 ​ 55 – 80 mmHg 55\text{--}80 \text{ mmHg} 55 – 80 mmHg or S p O 2 SpO_2 Sp O 2 ​ 88–95%) while avoiding cardiac preload compromise.

Rescue Therapies for Severe ARDS

When mechanical ventilation alone fails to achieve adequate oxygenation ( P / F ≤ 150 mmHg P/F \le 150 \text{ mmHg} P / F ≤ 150 mmHg ), advanced evidence-based rescue interventions are implemented:

1. Prone Positioning

Prone positioning is recommended for patients with severe ARDS ( P / F < 150 mmHg P/F < 150 \text{ mmHg} P / F < 150 mmHg with P E E P ≥ 10 cmH 2 O PEEP \ge 10 \text{ cmH}_2\text{O} PEEP ≥ 10 cmH 2 ​ O ) for at least 16 consecutive hours per day (PROSEVA trial protocol).

Physiological Rationale: Placed prone, ventral pulmonary segments become dependent, while dorsal lung regions are relieved of cardiac and abdominal compression. This redistributes perfusion toward better-ventilated alveoli, dramatically improving V/Q matching and recruiting atelectatic dorsal lung units.

Nursing Care: Secure endotracheal tube, central lines, and invasive monitoring prior to turns. Utilize specialized rotating beds or manual multi-person turn teams. Monitor pressure points (face, chest, knees, pelvis) to prevent skin breakdown.

2. Neuromuscular Blockade (NMB)

Early continuous infusion of neuromuscular blocking agents (e.g., cisatracurium) for 24–48 hours in severe ARDS reduces patient-ventilator dyssynchrony, lowers oxygen consumption, and eliminates chest wall resistance. Adequate deep sedation must always precede paralysis.

3. Inhaled Pulmonary Vasodilators

Inhaled Epoprostenol (prostacyclin) or Inhaled Nitric Oxide (iNO) selective vasodilates microvascular beds in ventilated lung units, shunting blood away from non-ventilated areas to improve P/F ratio without causing systemic hypotension.

4. Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO)

For refractory hypoxemic respiratory failure ( P / F < 80 mmHg P/F < 80 \text{ mmHg} P / F < 80 mmHg despite optimal LTVV, prone positioning, and NMB), VV-ECMO provides complete extracorporeal gas exchange, permitting ultra-lung-protective ventilation ( V t V_t V t ​ 2–3 mL/kg, low driving pressure) to allow pulmonary healing.